找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Disease; Management and Thera Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019Latest edition Springer Nature Switzerland AG 2019 b

[復(fù)制鏈接]
樓主: Weber-test
31#
發(fā)表于 2025-3-26 22:40:37 | 只看該作者
Evaluation of Patients for Metastases Prior to Primary Therapys in breast cancer patients is by patient signs and symptoms including history and physical examination, laboratory tests, imaging, biopsy of suspicious finding in imaging studies, and monitoring serum markers.
32#
發(fā)表于 2025-3-27 04:22:42 | 只看該作者
33#
發(fā)表于 2025-3-27 06:26:23 | 只看該作者
Biopsy Techniques in Nonpalpable or?Palpable Breast Lesionsassic surgical incisional and excisional biopsies. Fine-needle aspiration (FNA) has an important historical role and remains among the most cost-effective methods but is limited by the weakness of current breast cytology to adequately reproduce all information provided by traditional histopathology.
34#
發(fā)表于 2025-3-27 10:11:50 | 只看該作者
Evaluation of Patients for Metastases Prior to Primary Therapyto axillary surgery for SLNB or ALND or to neoadjuvant chemotherapy in those with axillary node-positive disease. However, there is no perfect modality to identify metastatic disease in breast cancer; every diagnostic test has its own advantages and limitations. The available evidence suggests routi
35#
發(fā)表于 2025-3-27 16:22:28 | 只看該作者
Breast Cancer Staging prognosis of patients with newly diagnosed breast cancer. According to the seventh revised edition of the TNM system in 2009, the presence of isolated tumor cells (ITCs) or micrometastases in axillary lymph nodes has little impact on survival. Furthermore, due to the increasing application of neoad
36#
發(fā)表于 2025-3-27 21:39:10 | 只看該作者
37#
發(fā)表于 2025-3-27 22:51:42 | 只看該作者
38#
發(fā)表于 2025-3-28 05:31:54 | 只看該作者
39#
發(fā)表于 2025-3-28 06:19:03 | 只看該作者
Adjuvant Systemic Therapy: Endocrine Therapy5% of all breast cancers. Adjuvant endocrine therapy is a pivotal component of treatment for women with hormone receptor-positive early-stage breast cancer; it delays local and distant relapse and prolongs survival. Patients with ER- and/or PR-positive invasive breast cancers should be considered fo
40#
發(fā)表于 2025-3-28 12:48:28 | 只看該作者
Adjuvant Systemic Chemotherapy for HER2-Negative Diseasepy. All patients with invasive breast cancer should be evaluated to assess the need for adjuvant cytotoxic therapy, trastuzumab, and/or endocrine therapy. If patients must receive endocrine therapy (either tamoxifen or aromatase inhibitor) and cytotoxic therapy as adjuvant therapy, chemotherapy shou
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 12:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
梁河县| 竹山县| 汉沽区| 卢湾区| 永丰县| 班戈县| 扎鲁特旗| 英吉沙县| 绵阳市| 南郑县| 武隆县| 钦州市| 兖州市| 中江县| 仪征市| 巴林左旗| 湄潭县| 竹溪县| 金华市| 承德县| 贵港市| 阿拉善盟| 砚山县| 内黄县| 五常市| 石河子市| 阳朔县| 利辛县| 德惠市| 苏尼特左旗| 石狮市| 大英县| 从化市| 磐安县| 马尔康县| 清苑县| 泌阳县| 安阳市| 滁州市| 封开县| 开原市|